Caplin Point Laboratories informs about press release

23 Apr 2025 Evaluate
Caplin Point Laboratories has informed that it enclosed a Press Release regarding receipt of final approval by its Subsidiary Caplin Steriles from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Phytonadione Injectable Emulsion USP, 10 mg/mL, Single Dose Vial, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) VITAMIN K1 Injection, from Hospira Inc. 

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1952.40 25.50 (1.32%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×